Well, we’re emerging from this one—the signs of that are all around. Immunization rates are climbing, moving us closer toward herd immunity. Infection outbreaks in the emerging world are ramping up the availability of vaccines for those worst hit. And output is surging as economies resume business activity. Evidence of the return to full production is everywhere, no more than in surging prices. If so, what will things look like? Let’s have a look at what could be for certain key functions.
The bottom line?
This commentary is presented for informational purposes only. It’s not intended to be a comprehensive or detailed statement on any subject and no representations or warranties, express or implied, are made as to its accuracy, timeliness or completeness. Nothing in this commentary is intended to provide financial, legal, accounting or tax advice nor should it be relied upon. EDC nor the author is liable whatsoever for any loss or damage caused by, or resulting from, any use of or any inaccuracies, errors or omissions in the information provided.